{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Medtech Innovation Podcast","title":"His secret to bypassing the broken venture capital model","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/90b86182\"></iframe>","width":"100%","height":180,"duration":5418,"description":"I'm joined by Jeff June, MedTech Founder and Ecosystem Builder, as we explore the broken venture capital model in healthcare, why accelerator programs are failing early-stage companies, and his battle-tested strategies for building successful MedTech ventures through strategic partnerships and ecosystem development.\nIn this episode, we dive deep into:\nThe Funding Crisis Reality Check\n→ Why venture capital has transformed into private equity, abandoning true early-stage companies\n→ How founders are achieving FDA clearance and $500K revenue without raising venture capital\n→ The massive disconnect between what VCs fund versus what MedTech innovation actually needs\nThe Accelerator Industrial Complex Problem\n→ Why sponsor-driven programs select companies through the lens of corporate partners, not innovation merit\n→ How success metrics focused on \"total funding raised\" create perverse incentives that harm true innovators\n→ The power of micro-accelerators and peer learning over brand-name program marketing\nTechnical Founders Are More Capable Than They Think\n→ Why being told to \"find an experienced CEO\" is the worst advice technical founders receive\n→ How clinical founders should lead with their expertise story, not generic market-size slides\n→ The critical difference between selling yourself first versus selling your technology\nThe Clinical-to-Consumer Healthcare Revolution\n→ How patient education and responsibility can solve healthcare's innovation adoption crisis\n→ Why great clinical innovations fail when they don't fit reimbursement models\n→ The untapped opportunity for consumer health technologies with clinical validation\nIschemia Care: A $15M Success Story\n→ How Jeff's stroke diagnostics company accomplished what others needed $120M to achieve\n→ Building ecosystems of clinicians, hospitals, payers, and strategics for maximum leverage\n→ The first blood test for stroke and lessons from commercializing breakthrough diagnostics\nStrategic Partnership Acquisition...","thumbnail_url":"https://img.transistorcdn.com/SKJTlzh1Dih_UjWAMpaf9asEOJluhYL_CM3FATuVvVc/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yM2U1/NjA3NjAzY2M1NDA0/ZDZkYTRiY2Y3Mjky/MTRmNi5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}